A carregar...
Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study
BACKGROUND: Negative symptoms and diminished cognitive ability are also considered as core features of schizophrenia. There are many studies in which negative symptoms and cognitive impairments are individually treated with atypical antipsychotic in comparison with either a placebo or a typical anti...
Na minha lista:
| Publicado no: | Ind Psychiatry J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261210/ https://ncbi.nlm.nih.gov/pubmed/25535442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0972-6748.144953 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|